Get started
Author

Matthias Kochanek

Observed names: Kochanek, Matthias, M Kochanek, M. Kochanek, Matthias, Kochanek
Observed institutions: Centers for Disease Control and Prevention, University of Bonn, Philipps University of Marburg, University of Cologne, Heidelberg University, University of Münster, University Hospital Münster, Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie, German Society of Medical Intensive Care and Emergency Medicine, Renewable Energy Alaska Project, Elbe Kliniken Stade-Buxtehude, Centrum für Integrierte Onkologie, University Hospital Cologne, Canadian Critical Care Trials Group, Medical University of Vienna
ORCID: 0000-0002-4766-4651
Observed ORCID: 0000-0002-4766-4651
OpenAlex ID: A5028623546
Cytokine release syndrome
2018 · Alexander Shimabukuro-Vornhagen, Philipp Gödel, et al. · Journal for ImmunoTherapy of Cancer · 1,659
PDF
COVID‐19 associated pulmonary aspergillosis
2020 · Philipp Koehler, Oliver A. Cornely, et al. · Mycoses · 546
PDF
New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management
2017 · on behalf of the Intensive Care in Hematological and Oncological Patients (iCHOP) Collaborative Group, Frank Kroschinsky, et al. · Critical Care · 500
PDF
Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine
2005 · Marc Beyer, Matthias Kochanek, et al. · Blood · 492
Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015) – short version
2015 · DAS-Taskforce 2015, Baron, Ralf, et al. · Europe PMC (PubMed Central) · 319
Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19
2020 · Petra Bacher, Elisa Rosati, et al. · Immunity · 314
PDF
In vivo peripheral expansion of naive CD4+CD25highFoxP3+ regulatory T cells in patients with multiple myeloma
2006 · Marc Beyer, Matthias Kochanek, et al. · Blood · 301
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
2021 · François-Xavier Lescure, Hitoshi Honda, et al. · The Lancet Respiratory Medicine · 246
PDF
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology
2021 · Juergen Prattes, Joost Wauters, et al. · Clinical Microbiology and Infection · 233
PDF
Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO)
2019 · Matthias Kochanek, E. Schalk, et al. · Annals of Hematology · 188
PDF
Central venous catheter–related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
2020 · Boris Böll, Enrico Schalk, et al. · Annals of Hematology · 166
PDF
Mucormycosis treated with posaconazole: review of 96 case reports
2012 · Joerg J. Vehreschild, Andrea Birtel, et al. · Critical Reviews in Microbiology · 148
Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19
2022 · Simin  Florescu, Delia Stanciu, et al. · JAMA · 146
PDF
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
2022 · Simin  Florescu, Delia Stanciu, et al. · JAMA · 136
PDF
Critical care of patients with cancer
2016 · Alexander Shimabukuro‐Vornhagen, Boris Böll, et al. · CA A Cancer Journal for Clinicians · 134
PDF
In the Eye of the Storm: Immune‐mediated Toxicities Associated With CAR‐T Cell Therapy
2019 · Jorge Garcia Borrega, Philipp Gödel, et al. · HemaSphere · 133
Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)
2018 · Tobias Welte, R. Phillip Dellinger, et al. · Intensive Care Medicine · 132
PDF
Mild therapeutic hypothermia in cardiogenic shock syndrome*
2012 · Carsten Zobel, Christoph Adler, et al. · Critical Care Medicine · 125
New Lineage of Lassa Virus, Togo, 2016
2018 · Shannon L.M. Whitmer, Thomas Strecker, et al. · Emerging infectious diseases · 123
Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis
2014 · Roman Pfister, Matthias Kochanek, et al. · Critical Care · 106
PDF
Respiratory indications for ECMO: focus on COVID-19
2022 · Alexander Supady, Alain Combes, et al. · Intensive Care Medicine · 99
PDF
Consensus statement for cancer patients requiring intensive care support
2018 · M. G. Kiehl, G. Beutel, et al. · Annals of Hematology · 97
PDF
Community acquired respiratory virus infections in cancer patients—Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology
2016 · Marie von Lilienfeld-Toal, Annemarie Berger, et al. · European Journal of Cancer · 92
Intensive care management of influenza-associated pulmonary aspergillosis
2019 · P. Koehler, M. Bassetti, et al. · Clinical Microbiology and Infection · 82
Characteristics and Outcome of Patients After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome*
2017 · Philipp Wohlfarth, Gernot Beutel, et al. · Critical Care Medicine · 82
Works count: 261
Citation count: 8,805
H-index: 41
I10-index: 87
Year
Topic
Type